CVA Family Office’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$178K Buy
400
+32
+9% +$15K 0.02% 355
2026
Q1
$146K Buy
368
+91
+33% +$41.1K 0.02% 379
2025
Q4
$130K Sell
277
-53
-16% -$23.5K 0.02% 366
2025
Q3
$163K Buy
330
+16
+5% +$9.04K 0.02% 327
2025
Q2
$161K Buy
314
+56
+22% +$26.1K 0.02% 327
2025
Q1
$111K Sell
258
-37
-13% -$18K 0.02% 374
2024
Q4
$143K Buy
295
+33
+13% +$17.3K 0.02% 325
2024
Q3
$133K Buy
262
+2
+0.8% +$1.07K 0.02% 322
2024
Q2
$155K Buy
260
+10
+4% +$5.66K 0.03% 285
2024
Q1
$143K Buy
250
+1
+0.4% +$550 0.03% 299
2023
Q4
$128K Buy
+249
New +$127K 0.03% 299
2023
Q3
Sell
-244
Closed -$106K 829
2023
Q2
$106K Hold
244
0.02% 303
2023
Q1
$94.2K Buy
244
+44
+22% +$15.7K 0.02% 319
2022
Q4
$63.9K Sell
200
-35
-15% -$11K 0.02% 365
2022
Q3
$72K Buy
235
+5
+2% +$1.69K 0.02% 292
2022
Q2
$70K Buy
230
+60
+35% +$18.1K 0.02% 297
2022
Q1
$57K Buy
170
+75
+79% +$23.4K 0.01% 371
2021
Q4
$35K Buy
+95
New +$32K 0.01% 425
2021
Q3
Sell
-95
Closed -$26K 803
2021
Q2
$26K Hold
95
0.01% 479
2021
Q1
$24K Buy
+95
New +$24.1K 0.01% 377

Other funds holding SNPS

CVA Family Office's SNPS Position: Q2 2026 in Review

CVA Family Office increased its Synopsys (SNPS) stake by 8.7% in Q2 2026, buying an estimated $15K and bringing the position to 400 shares worth $178K. The position accounts for 0.02% of the portfolio, ranked #355.

CVA Family Office first reported a position in SNPS in Q1 2021 and has held it in 20 quarters since. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • CVA Family Office held 400 shares of Synopsys worth $178K as of Q2 2026.
  • CVA Family Office bought 32 Synopsys shares in Q2 2026, an estimated $15K.
  • Synopsys made up 0.02% of CVA Family Office's portfolio in Q2 2026, its #355 holding.
  • CVA Family Office first reported a position in Synopsys in Q1 2021 and has held it in 20 quarters since.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.